RxSight, Inc.

RXST· Nasdaq· Ophthalmic Goods

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
-14.4%
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
+55.7%
We record prices for the companies we cover; RXST is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
40.9M
Revenue
$134.5M
Free cash flow
-$19.3M
Owner earnings
-$51.0M

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
76.6%
Operating
-35.8%
Net
-29.0%
Free cash flow
-14.4%
Owner earnings
-37.9%
Stock pay
23.5%

Returns

ROIC, FY2025
–
ROIC, 5 yr avg
–
ROE, FY2025
-14.1%
ROE, 5 yr avg
-32.7%

Growth (CAGR)

Revenue, 3 yr
40.0%
Revenue, 5 yr
55.7%
Diluted EPS, 3 yr
–
Diluted EPS, 5 yr
–
Free cash flow, 3 yr
–
Free cash flow, 5 yr
–

Financial health · FY2025

Cash and investments
$228.1M
Total debt
–
Net cash
–
Debt/Equity
–
Debt/FCF
–

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
–
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
49.2%

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$134.5M

+55.7% a year over 5 years

FY2020: Revenue $14.7MFY2021: Revenue $22.6MFY2022: Revenue $49.0MFY2023: Revenue $89.1MFY2024: Revenue $139.9MFY2025: Revenue $134.5M
FY2020FY2025

Margins

Gross76.6%Operating-35.8%Net-29.0%

FY2025

FY2020: Gross 11.6%, Operating -241.3%, Net 187.9%FY2021: Gross 20.0%, Operating -233.6%, Net -215.5%FY2022: Gross 43.5%, Operating -129.2%, Net -136.2%FY2023: Gross 60.4%, Operating -56.2%, Net -54.6%FY2024: Gross 70.7%, Operating -26.3%, Net -19.6%FY2025: Gross 76.6%, Operating -35.8%, Net -29.0%
FY2020FY2025

Free cash flow and owner earnings

Free cash flow-$19.3MOwner earnings-$51.0M

FY2025

FY2020: Free cash flow -$37.7M, Owner earnings -$41.9MFY2021: Free cash flow -$46.6M, Owner earnings -$54.2MFY2022: Free cash flow -$61.2M, Owner earnings -$72.6MFY2023: Free cash flow -$46.4M, Owner earnings -$62.2MFY2024: Free cash flow -$22.4M, Owner earnings -$47.0MFY2025: Free cash flow -$19.3M, Owner earnings -$51.0M
FY2020FY2025

Diluted shares

40.9M

+638.4% over 5 years, net dilution

FY2020: Diluted shares 5.5MFY2021: Diluted shares 13.6MFY2022: Diluted shares 27.7MFY2023: Diluted shares 34.5MFY2024: Diluted shares 38.9MFY2025: Diluted shares 40.9M
FY2020FY2025

Net cash

–

$127.2M more cash than debt

FY2020: Net cash $44.6MFY2021: Net cash $119.6MFY2022: Net cash $65.6MFY2023: Net cash $127.2MFY2024: Net cash –FY2025: Net cash –
FY2020FY2025

Every figure, year by year

Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
The business
Revenue$14.7M$22.6M$49.0M$89.1M$139.9M$134.5M
Revenue growth–53.9%116.9%81.8%57.1%-3.9%
Gross margin11.6%20.0%43.5%60.4%70.7%76.6%
Operating margin-241.3%-233.6%-129.2%-56.2%-26.3%-35.8%
Net income$27.6M-$48.7M-$66.8M-$48.6M-$27.5M-$38.9M
Net margin187.9%-215.5%-136.2%-54.6%-19.6%-29.0%
Diluted EPS$0.15$-3.57$-2.41$-1.41$-0.71$-0.95
Return on invested capital?––––––
Cash
Operating cash flow-$35.2M-$44.7M-$58.9M-$41.6M-$16.9M-$15.5M
Capital expenditure$2.5M$1.9M$2.4M$4.8M$5.4M$3.8M
Free cash flow-$37.7M-$46.6M-$61.2M-$46.4M-$22.4M-$19.3M
Stock-based compensation$4.2M$7.6M$11.4M$15.7M$24.6M$31.6M
Owner earnings?-$41.9M-$54.2M-$72.6M-$62.2M-$47.0M-$51.0M
Free cash flow per share$-6.82$-3.42$-2.21$-1.35$-0.58$-0.47
Capital allocation
Dividends paid––––––
Share repurchases––––––
Diluted shares5.5M13.6M27.7M34.5M38.9M40.9M
Share count change?–146.3%103.0%24.6%12.8%5.1%
Balance sheet
Cash and equivalents$14.0M$24.4M$11.8M$9.7M$16.7M$19.9M
Short-term investments$55.0M$135.0M$94.0M$117.5M$220.5M$208.2M
Total debt$24.4M$39.8M$40.2M$0––
Net debt-$44.6M-$119.6M-$65.6M-$127.2M––
Shareholders' equity-$430.6M$138.2M$89.9M$160.4M$281.2M$275.7M

Latest filings

All on EDGAR
2026-08-0510-QQuarterly report
2026-08-058-KEarnings release
2026-07-068-KEarnings release
2026-05-0610-QQuarterly report
2026-05-068-KEarnings release
2026-04-28DEF 14AProxy statement
2026-02-2510-KAnnual report
2026-02-258-KEarnings release
2026-01-128-KEarnings release
2025-11-0510-QQuarterly report

More from our coverage

All coverage